DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea · Delayed Price · Currency is KRW 18,580
+350 (1.92%)
Jul 27, 2026, 2:50 PM KST
DongKook Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 954,164 | 926,884 | 812,166 | 730,994 | 661,647 | 594,193 |
Revenue Growth | 13.71% | 14.12% | 11.10% | 10.48% | 11.35% | 6.28% |
Gross Profit Gross Profit Growth | 522,147 | 501,228 | 447,568 | 410,551 | 379,648 | 349,921 |
Operating Income Operating Income Growth | 98,533 | 96,474 | 79,865 | 66,873 | 73,541 | 63,219 |
Net Income Net Income Growth | 74,518 | 66,020 | 60,769 | 46,775 | 52,896 | 50,345 |
Earnings Per Share EPS Growth | 1659.97 | 1475.00 | 1368.41 | 1054.64 | 1183.00 | 1126.00 |
EPS Growth | 27.96% | 7.79% | 29.75% | -10.85% | 5.06% | -9.99% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Beauty Device Beauty Device Growth | 7,732 | 8,264 | 3,578 | - | - | - |
Cosmetics Cosmetics Growth | 44,154 | 39,001 | 9,229 | - | - | - |
Pharmaceuticals Pharmaceuticals Growth | 924,477 | 897,248 | 814,724 | 740,091 | 675,316 | 618,052 |
Elimination of Inter-Segment Profits Elimination of Inter-Segment Profits Growth | -22,198 | -17,630 | -15,365 | -9,097 | -13,668 | -23,859 |
Total Total Growth | 954,164 | 926,884 | 812,166 | 730,994 | 661,647 | 594,193 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 118,361 | 127,102 | 90,854 | 94,160 | 107,105 | 169,929 |
Total Debt Total Debt Growth | 67,980 | 76,240 | 80,687 | 76,704 | 66,357 | 97,922 |
Net Cash (Debt) Net Cash Growth | 50,381 | 50,862 | 10,167 | 17,456 | 40,748 | 72,008 |
Net Cash Growth | 32.29% | 400.27% | -41.76% | -57.16% | -43.41% | -33.18% |
Net Cash Per Share Net Cash Per Share Growth | 1122.34 | 1136.38 | 227.26 | 390.25 | 911.09 | 1610.23 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 80,512 | 68,760 | 76,091 | 41,793 | 40,909 | 44,654 |
Capital Expenditures CapEx Growth | -51,199 | -42,715 | -27,291 | -34,177 | -47,914 | -51,006 |
Free Cash Flow Free Cash Flow Growth | 29,313 | 26,046 | 48,800 | 7,616 | -7,005 | -6,352 |
Free Cash Flow Growth | -38.18% | -46.63% | 540.73% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.72% | 54.08% | 55.11% | 56.16% | 57.38% | 58.89% |
Operating Margin | 10.33% | 10.41% | 9.83% | 9.15% | 11.12% | 10.64% |
Pretax Margin | 10.49% | 9.99% | 10.43% | 8.32% | 10.37% | 11.74% |
Profit Margin | 7.81% | 7.12% | 7.48% | 6.40% | 7.99% | 8.47% |
FCF Margin | 3.07% | 2.81% | 6.01% | 1.04% | -1.06% | -1.07% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 200.000 | 200.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 1.10% | 1.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.98 | 11.62 | 11.95 | 15.19 | 13.79 | 19.03 |
Forward PE | 8.63 | 9.87 | 11.01 | 11.66 | 11.64 | 15.82 |
P/FCF Ratio | 28.05 | 29.46 | 14.88 | 93.28 | - | - |
PS Ratio | 0.86 | 0.83 | 0.89 | 0.97 | 1.10 | 1.61 |